USFDA Inspection Concludes at Aurobindo Pharma's Subsidiary Facility

Aurobindo Pharma announced on Tuesday that the US Food and Drug Administration (USFDA) has completed an inspection of a manufacturing facility owned by its subsidiary, Apitoria Pharma Pvt Ltd, with two observations.

The inspected facility, known as Unit-V, is located at Pashamylaram village in Patancheru mandal of Sanga Reddy district in Telangana and specializes in the production of active pharmaceutical ingredients (API). The inspection took place between December 9-17, 2022.

Procedural Observations to be Addressed

Aurobindo Pharma clarified in a regulatory filing that the observations made by the USFDA are procedural in nature and will be responded to within the stipulated time. Apitoria Pharma is a wholly-owned subsidiary of Aurobindo Pharma.

The company's stock experienced a 2.5% decline, closing at Rs 1213.45 on the Bombay Stock Exchange, compared to the previous day's closing of Rs 1245.